522 related articles for article (PubMed ID: 16784383)
1. Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004).
Boston SE; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
J Am Vet Med Assoc; 2006 Jun; 228(12):1905-8. PubMed ID: 16784383
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991).
Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty MH; Powers BE; Withrow SJ
J Am Vet Med Assoc; 1993 Jan; 202(2):304-6. PubMed ID: 8428842
[TBL] [Abstract][Full Text] [Related]
3. The impact of pamidronate and chemotherapy on survival times in dogs with appendicular primary bone tumors treated with palliative radiation therapy.
Oblak ML; Boston SE; Higginson G; Patten SG; Monteith GJ; Woods JP
Vet Surg; 2012 Apr; 41(3):430-5. PubMed ID: 23253085
[TBL] [Abstract][Full Text] [Related]
4. Limb-sparing treatment for osteosarcoma in dogs.
LaRue SM; Withrow SJ; Powers BE; Wrigley RH; Gillette EL; Schwarz PD; Straw RC; Richter SL
J Am Vet Med Assoc; 1989 Dec; 195(12):1734-44. PubMed ID: 2599960
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006-2010).
Simcock JO; Withers SS; Prpich CY; Kuntz CA; Rutland BE
J Am Vet Med Assoc; 2012 Sep; 241(5):608-14. PubMed ID: 22916858
[TBL] [Abstract][Full Text] [Related]
8. TP53 gene mutations in canine osteosarcoma.
Kirpensteijn J; Kik M; Teske E; Rutteman GR
Vet Surg; 2008 Jul; 37(5):454-60. PubMed ID: 18986312
[TBL] [Abstract][Full Text] [Related]
9. [Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors].
Ham SJ; Kroon HM; Schraffordt Koops H; Hoekstra HJ
Ned Tijdschr Geneeskd; 2000 Jan; 144(3):121-5. PubMed ID: 10674118
[TBL] [Abstract][Full Text] [Related]
10. Palliative radiotherapy with electrons of appendicular osteosarcoma in 54 dogs.
Mueller F; Poirier V; Melzer K; Nitzl D; Roos M; Kaser-Hotz B
In Vivo; 2005; 19(4):713-6. PubMed ID: 15999538
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992).
McNiel EA; Ogilvie GK; Powers BE; Hutchison JM; Salman MD; Withrow SJ
J Am Vet Med Assoc; 1997 Dec; 211(11):1422-7. PubMed ID: 9394893
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma.
Withrow SJ; Liptak JM; Straw RC; Dernell WS; Jameson VJ; Powers BE; Johnson JL; Brekke JH; Douple EB
Ann Surg Oncol; 2004 Jul; 11(7):705-13. PubMed ID: 15231525
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma: 90 cases (1997-2008).
Culp WT; Olea-Popelka F; Sefton J; Aldridge CF; Withrow SJ; Lafferty MH; Rebhun RB; Kent MS; Ehrhart N
J Am Vet Med Assoc; 2014 Nov; 245(10):1141-6. PubMed ID: 25356715
[TBL] [Abstract][Full Text] [Related]
14. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation.
Kirpensteijn J; Teske E; Kik M; Klenner T; Rutteman GR
Anticancer Res; 2002; 22(5):2765-70. PubMed ID: 12529994
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004).
Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ
J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003).
Rassnick KM; Goldkamp CE; Erb HN; Scrivani PV; Njaa BL; Gieger TL; Turek MM; McNiel EA; Proulx DR; Chun R; Mauldin GE; Phillips BS; Kristal O
J Am Vet Med Assoc; 2006 Aug; 229(3):401-6. PubMed ID: 16881833
[TBL] [Abstract][Full Text] [Related]
17. Prognosis for dogs with stage III osteosarcoma following treatment with amputation and chemotherapy with and without metastasectomy.
Turner H; Séguin B; Worley DR; Ehrhart NP; Lafferty MH; Withrow SJ; Selmic LE
J Am Vet Med Assoc; 2017 Dec; 251(11):1293-1305. PubMed ID: 29154712
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prognostic factors in the surgical treatment of adrenal gland tumors in dogs: 41 cases (1999-2005).
Schwartz P; Kovak JR; Koprowski A; Ludwig LL; Monette S; Bergman PJ
J Am Vet Med Assoc; 2008 Jan; 232(1):77-84. PubMed ID: 18167113
[TBL] [Abstract][Full Text] [Related]
19. Multilobular osteochondrosarcoma in 39 dogs: 1979-1993.
Dernell WS; Straw RC; Cooper MF; Powers BE; LaRue SM; Withrow SJ
J Am Anim Hosp Assoc; 1998; 34(1):11-8. PubMed ID: 9527424
[TBL] [Abstract][Full Text] [Related]
20. Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma.
Dimopoulou M; Kirpensteijn J; Moens H; Kik M
Vet Surg; 2008 Jul; 37(5):466-71. PubMed ID: 18986314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
